Real World Use, Effectiveness and Safety of Teprotumumab among Thyroid Eye Disease Patients treated in China BOAO Pilot Zone: A Retrospective Cohort Study (20240345)

30/06/2025
18/02/2026
EU PAS number:
EUPAS1000000625
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

20240345 Protocol-Published Original teprotumumab-trbw redacted.pdf

English (15.84 MB - PDF) View document
Study results
Study report
Other information